- Home
- FET vs TLSI Comparison
FET vs TLSI Comparison
Compare FET & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FET
- TLSI
- Stock Information
- Founded
- FET 2005
- TLSI 2010
- Country
- FET United States
- TLSI United States
- Employees
- FET N/A
- TLSI N/A
- Industry
- FET Metal Fabrications
- TLSI Medical Specialities
- Sector
- FET Industrials
- TLSI Health Care
- Exchange
- FET Nasdaq
- TLSI Nasdaq
- Market Cap
- FET 240.1M
- TLSI 204.0M
- IPO Year
- FET 2012
- TLSI N/A
- Fundamental
- Price
- FET $18.69
- TLSI $3.85
- Analyst Decision
- FET
- TLSI Strong Buy
- Analyst Count
- FET 0
- TLSI 5
- Target Price
- FET N/A
- TLSI $10.90
- AVG Volume (30 Days)
- FET 79.6K
- TLSI 39.5K
- Earning Date
- FET 08-07-2025
- TLSI 08-12-2025
- Dividend Yield
- FET N/A
- TLSI N/A
- EPS Growth
- FET N/A
- TLSI N/A
- EPS
- FET N/A
- TLSI N/A
- Revenue
- FET $807,312,000.00
- TLSI $32,141,000.00
- Revenue This Year
- FET N/A
- TLSI $55.39
- Revenue Next Year
- FET $1.56
- TLSI $54.89
- P/E Ratio
- FET N/A
- TLSI N/A
- Revenue Growth
- FET 7.31
- TLSI 46.20
- 52 Week Low
- FET $12.78
- TLSI $3.50
- 52 Week High
- FET $21.57
- TLSI $6.04
- Technical
- Relative Strength Index (RSI)
- FET 44.06
- TLSI 34.25
- Support Level
- FET $19.12
- TLSI $4.10
- Resistance Level
- FET $20.80
- TLSI $4.30
- Average True Range (ATR)
- FET 0.79
- TLSI 0.24
- MACD
- FET -0.23
- TLSI -0.02
- Stochastic Oscillator
- FET 18.85
- TLSI 21.79
About FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.